−176.94 MUSD
14.09 MUSD
39.25 M
About NewAmsterdam Pharma Company N.V.
Sector
CEO
Michael H. Davidson
Headquarters
Naarden
Website
Founded
2022
ISIN
NL00150012L7
FIGI
BBG01BNNTQN4
NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. Its lead product candidate, Obicetrapib, is a next-generation, oral, low-dose cholesteryl ester transfer protein inhibitor, which will be used to prevent major adverse cardiovascular events. The company was founded on June 10, 2022 and is headquartered in Naarden, the Netherlands.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NAMS is 21.99 USD — it has increased by 2.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NewAmsterdam Pharma Company N.V. stocks are traded under the ticker NAMS.
NAMS stock is 5.23% volatile and has beta coefficient of 3.13. Check out the list of the most volatile stocks — is NewAmsterdam Pharma Company N.V. there?
Yes, you can track NewAmsterdam Pharma Company N.V. financials in yearly and quarterly reports right on TradingView.
NAMS stock has risen by 14.47% compared to the previous week, the month change is a 3.59% fall, over the last year NewAmsterdam Pharma Company N.V. has showed a 57.07% increase.
Today NewAmsterdam Pharma Company N.V. has the market capitalization of 1.96 B, it has increased by 3.74% over the last week.
No, NAMS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NAMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NewAmsterdam Pharma Company N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NewAmsterdam Pharma Company N.V. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NewAmsterdam Pharma Company N.V. stock shows the buy signal. See more of NewAmsterdam Pharma Company N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NewAmsterdam Pharma Company N.V. future price: according to them, NAMS price has a max estimate of 37.00 USD and a min estimate of 28.00 USD. Read a more detailed NewAmsterdam Pharma Company N.V. forecast: see what analysts think of NewAmsterdam Pharma Company N.V. and suggest that you do with its stocks.